The Food and Drug Administration (FDA) conducted an inspection at Blood Center Mandeville Donor Center in Mandeville on March 24, reviewing blood and blood products, according to data provided on the FDA’s website.
The final report showed that Blood Center Mandeville Donor Center was determined to need no corrective action for its operational management.
The FDA regularly inspects facilities throughout the United States to assess if workplaces and products meet FDA guidelines and laws aimed at benefiting public health. Inspection reports are made available to the public.
Its website indicates the FDA is responsible for overseeing the safety and quality of human and animal drugs, biological products, medical devices and tobacco goods.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
